Filing Flows

Filing Flows › Companies › Elite Health Systems › Cash flow

Elite Health Systems cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$1.4M in Q2 2026 · −$4.9M over twelve months

Operating cash flow−$1.4M
Free cash flow−$1.4M

Analysis

In Q2 2026, Elite Health Systems generated −$1.4M of operating cash flow. That is $1.0M less than in Q2 2025 (−$334K).

Over the twelve months to Jun 30, 2026, operating cash flow was −$4.9M; the largest uses were operating cash flow ($4.9M), other investing ($308K); besides operations, cash came from other financing ($3.4M), shares issued ($30K); the cash balance fell by $1.8M.

Operating cash flow was −$1.4M against net income of −$1.5M. The largest differences: receivables +$72K, prepaid and other assets +$72K, payables −$42K.

Free cash flow

Elite Health Systems: free cash flow by quarterElite Health Systems: free cash flow by quarter−$72KQ3 2024−$527KQ4 2024−$297KQ1 2025−$334KQ2 2025−$817KQ3 2025−$1.5MQ4 2025−$1.3MQ1 2026−$1.4MQ2 2026
Operating cash flow less capital spending.
Elite Health Systems: operating cash flow against capital spendingElite Health Systems: operating cash flow against capital spendingOperating cash flowCapital spending−$72K$0Q3 2024−$527K$0Q4 2024−$297K$0Q1 2025−$334K$0Q2 2025−$817K$0Q3 2025−$1.5M$0Q4 2025−$1.3M$0Q1 2026−$1.4M$0Q2 2026
Latest (Q2 2026): Operating cash flow −$1.4M, Capital spending $0.

Capital allocation, year by year

Elite Health Systems: where the cash came from (up) and went (down), by fiscal yearElite Health Systems: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsFY2021: Operating cash flow $174KFY2021: Net borrowing −$89K$174KFY2021FY2022: Operating cash flow −$1.4MFY2022: Acquisitions −$2KFY2022FY2023: Operating cash flow −$891KFY2023FY2024: Operating cash flow −$1.5MFY2024: Shares issued $92K$92KFY2024FY2025: Operating cash flow −$2.9MFY2025: Shares issued $44KFY2025: Capital spending −$7K$44KFY2025
Over these 5 years operating cash flow totalled −$6.6M; the largest uses were operating cash flow ($6.8M) and net borrowing ($89K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$1.3M
Debtnone
Net cash$1.3M
Cash runway3 months

Elite Health Systems is burning cash: its operations consume cash, a free cash flow of −$4.9M a year at the current rate against $1.3M of cash and investments: a runway of about 3 months before any new financing.

Where the cash came from and went

Elite Health Systems: sources (+) and uses (−) of cash, Q2 2026Elite Health Systems: sources (+) and uses (−) of cash, Q2 2026Operating cash flow−$1.4MCash drawn (+) / kept (−)$1.3MOther financing$53K
Elite Health Systems: sources (+) and uses (−) of cash, TTM to Q2 2026Elite Health Systems: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$4.9MOther financing$3.4MCash drawn (+) / kept (−)$1.8MOther investing−$308KShares issued$30K

From profit to cash

Elite Health Systems: net income to operating cash flow, Q2 2026Elite Health Systems: net income to operating cash flow, Q2 2026Net income−$1.5MStock-based pay$41KReceivables$72KPayables−$42KDeferred revenue−$24KPrepaid and other assets$72KOperating cash flow−$1.4M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowShares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$1.4M—$1.3M−$1.4M
Q1 2026−$1.3M—$1.2M−$1.3M
Q4 2025−$1.5M−$431K$212K−$1.5M
Q3 2025−$817K$461K−$849K−$817K
Q2 2025−$334K—$575K−$334K
Q1 2025−$297K$14K$338K−$297K
Q4 2024−$527K−$4.0M−$861K−$527K
Q3 2024−$72K$1.9M−$978K−$72K

Elite Health Systems: income statement and cash flow

Elite Health Systems, Q2 2026: revenue $1.3M, operating margin -117.6%. The chart follows the revenue to costs, profit and cash.

Elite Health Systems: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.